[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

COVID-19 and hypertension: the what, the why, and the how

SA Muhamad, A Ugusman, J Kumar, D Skiba… - Frontiers in …, 2021 - frontiersin.org
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …

[HTML][HTML] Circulating microRNAs as emerging regulators of COVID-19

Y Liang, D Fang, X Gao, X Deng, N Chen, J Wu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …

[HTML][HTML] Retinal manifestations in patients following COVID-19 infection: a consecutive case series

M Goyal, SI Murthy, S Annum - Indian journal of ophthalmology, 2021 - journals.lww.com
Purpose: To describe retinal manifestations seen in patients associated with COVID-19
infection at a multi-specialty tertiary care hospital in Southern India. Methods: In this …

Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action

MA Hill, JR Sowers, CS Mantzoros - Metabolism, 2021 - Elsevier
While substantial evidence points towards obesity and associated cardiometabolic disorders
being a major factor for poor outcomes in SARS-CoV2 infections (COVID-19), the complexity …

Resveratrol as an adjunctive therapy for excessive oxidative stress in aging COVID-19 patients

MT Liao, CC Wu, SFV Wu, MC Lee, WC Hu, KW Tsai… - Antioxidants, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic continues to burden healthcare
systems worldwide. COVID-19 symptoms are highly heterogeneous, and the patient may be …

Capillary leukocytes, microaggregates, and the response to hypoxemia in the microcirculation of coronavirus disease 2019 patients

E Favaron, C Ince, MP Hilty, B Ergin… - Critical Care …, 2021 - journals.lww.com
OBJECTIVES: In this study, we hypothesized that coronavirus disease 2019 patients exhibit
sublingual microcirculatory alterations caused by inflammation, coagulopathy, and …

Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties

HM Al-Kuraishy, AI Al-Gareeb, MM El-Bouseary… - Clinical and …, 2023 - Springer
Hyperviscosity syndrome (HVS) recently emerged as a complication of coronavirus disease
2019 (COVID-19) and COVID-19 vaccines. Therefore, the objectives of this critical review …

Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death

W Chen, JY Pan - Biological Procedures Online, 2021 - Springer
The spread of the coronavirus (SARS-CoV-2, COVID-19 for short) has caused a large
number of deaths around the world. We summarized the data reported in the past few …

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup

H Xu, S Sheng, W Luo, X Xu, Z Zhang - Frontiers in Immunology, 2023 - frontiersin.org
Acute respiratory distress syndrome (ARDS) is an acute diffuse inflammatory lung injury
characterized by the damage of alveolar epithelial cells and pulmonary capillary endothelial …